Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06162065Phase 1Unknown

Effectiveness of Oral Boldo in Women With Overactive Bladder

Role: collaborator

NCT02577302Not ApplicableUnknown

CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology

Role: lead

NCT05074329Not ApplicableUnknown

Clinical Trial for Idiopathic Hip Pain Using Peripheral Nerve Stimulation

Role: lead

NCT02434874Not ApplicableWithdrawn

Sacral Nerve Stimulation to Treat Urgency Urinary Incontinence With Wireless Neuromodulation

Role: lead

NCT02781636Not ApplicableTerminated

Protect Chronic Tibial Nerve Stimulator (CTNS) System

Role: lead

All 5 trials loaded